Sino Biological, Inc. is proud to announce the launch of its innovative SwiftFluo® TR-FRET Kinase Assay Kits, a ready-to-use, high-performance solution designed to accelerate kinase activity detection ...

Sino Biological, Inc. is proud to announce the launch of its innovative SwiftFluo TR-FRET Kinase Assay Kits, a ready-to-use, high-performance solution ...

The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

TEM hits $1.1B TCV, signs 70+ pharma data deals and posts its first positive adjusted EBITDA in Q3 2025 as adoption ...

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

Parse Biosciences & Graph Therapeutics partner to build large functional immune perturbation atlas: Seattle Thursday, January 22, 2026, 11:00 Hrs [IST] Parse Biosciences, a global ...

Many people are familiar with histamine, a biological molecule that serves as a key driver of allergic reactions and other ...

Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise ...

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

(Graph) today announced a strategic partnership to create one of the largest and most comprehensive immune cell perturbation atlases. The collaboration will leverage Graph's lab-in-the-loop platform ...